secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rallybio Corp (RLYB)
CIK:        0001739410
Form:       8-K
Filed at:   2026-11-06T22:26:49+00:00
Accession:  0001193125-26-452115
Event type: m_and_a
Sentiment:  negative
Materiality: 0.72
Item codes: 8.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Rallybio postpones Avenzo merger closing; cash distribution deposit delayed
---------------------------------------------------------------------------

- Merger with Avenzo Therapeutics and Farmington Merger Sub, dated May 31, 2026, will not close as anticipated on November 6, 2026.
- Unmet listing conditions for Rallybio shares post-closing prompted the postponement; parties continue seeking listing approvals.
- Rallybio did not deposit cash distribution funds with Computershare on November 5, 2026, so payment and ex-dividend dates may be delayed.
- No new closing date or distribution timetable was provided; company said it will give further updates as appropriate.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739410/000119312526452115/0001193125-26-452115-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739410/000119312526452115/d195147d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-452115

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer